Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Zwitserland
  4. Swiss Exchange
  5. Novartis AG
  6. Nieuws
  7. Persberichten
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť NOVARTIS AG
13/09NOVARTIS : announces first FDA filing acceptance for anti-PD-1 antibody tisleliz..
PU
08/09NOVARTIS : Sandoz strengthens pipeline by entering into agreement for biosimilar..
AQ
03/09NOVARTIS : presents new findings at ERS reinforcing the efficacy of Enerzairģ Br..
PU
02/09NOVARTIS : PTEs (patent term extensions) in Australia – More hard lessons ..
AQ
01/09ACURX PHARMACEUTICAL'S IS DISRUPTIVE : Acxp)
AQ
01/09NOVARTIS : World-first agreement between Novartis and the NHS enables broad and ..
PU
30/08NOVARTIS : Leqvioģ* (inclisiran) analyses show effective and sustained LDL-C red..
PU
26/08Acurx Pharmaceuticals Plan To Change The Antibiotics Landscape Is Simple- Mak..
AQ
25/08NOVARTIS : provides update on BELINDA study investigating Kymriah as second-line..
AQ
24/08NOVARTIS : provides update on BELINDA study investigating Kymriahģ as second-lin..
PU
18/08NOVARTIS : secures new approval in China for Cosentyx (secukinumab) in pediatric..
AQ
17/08Acurx Pharmaceutical's On Pace To Change The Antibiotics Landscape; Trial Dat..
AQ
17/08NOVARTIS : secures new approval in China for Cosentyxģ (secukinumab) in pediatri..
PU
17/08NOVARTIS : announces positive results from Phase III trials of Beovuģ in diabeti..
PU
12/08DRUG MAKERS OVERSEAS ARE GAINING A C : Acxp)
AQ
09/08GRAM POSITIVE BACTERIAL INFECTIONS C : Acxp)
AQ
03/08IONIS PHARMACEUTICALS : discovered pelacarsen continues to advance as potential ..
AQ
03/08NOVARTIS : announces lift of partial clinical trial hold and plans to initiate a..
PU
22/07NOVARTIS : ESG Update - July 22, 2021
PU
21/07NOVARTIS : Yes ☐ No ☒ (Form 6-K)
PU
21/07NOVARTIS : Q2 Earnings Snapshot
AQ
21/07NOVARTIS : Download the interactive presentation (PDF 4.5 MB)
PU
21/07NOVARTIS : Q2 2021 results Media release English
PU
20/07NOVARTIS : pledges 10-year commitment with Morehouse School of Medicine, 26 Hist..
PU
16/07AUROBINDO PHARMA : Receives FDA Approval for Baclofen Tablets USP, 10 mg and 20 ..
AQ
14/07NOVARTIS : announces NEJM publication of positive Phase III REACH3 data for Jaka..
PU
02/07FEDERAL COURT DISMISSES ROCHE'S PMNO : Pirfenidone
AQ
28/06NOVARTIS : International AG Novartis Global Communications CH-4002 Basel Switzer..
PU
23/06NOVARTIS : Positive survival data for Novartis investigational radioligand thera..
PU
23/06NOVARTIS : Kesimpta data show long-term preservation of IgG/IgM levels and no in..
AQ
23/06NOVARTIS : and Hewlett Packard Enterprise join forces to advance Novartis global..
PU
22/06NOVARTIS : Kesimptaģ (ofatumumab) data show long-term preservation of IgG/IgM le..
PU
14/06NOVARTIS : investigational oral therapy iptacopan (LNP023) shows benefit as mono..
AQ
07/06NOVARTIS : announces new interim analysis Phase II data for iptacopan in rare ki..
PU
03/06NOVARTIS : Kymriah pivotal trial demonstrates strong response rates and a remark..
AQ
27/05ETON PHARMACEUTICALS : Particularity In Petitions Produces Positive Post-Grant R..
AQ
18/05NOVARTIS : Sandoz announces plans to further strengthen its antibiotics manufact..
AQ
18/05NOVARTIS : reaches milestone delivery of 1 billion courses of antimalarial treat..
PU
03/05NOVARTIS : Sandoz confirms late-stage clinical development plans for proposed bi..
AQ
28/04NOVARTIS : ESG Update - April 28, 2021 (PDF 0.3 MB)
PU
27/04NOVARTIS : Q1 Earnings Snapshot
AQ
27/04NOVARTIS : Q1 2021 Results Investor presentation
PU
27/04NOVARTIS : Interim financial report (PDF 0.4 MB)
PU
23/04NOVARTIS : to initiate SMART Phase 3b global study of Zolgensma in children up t..
PU
19/04NOVARTIS : Kesimpta (ofatumumab) data at AAN showed reduction in disability prog..
AQ
16/04NOVARTIS : Kesimptaģ (ofatumumab) data at AAN showed reduction in disability pro..
PU
15/04NOVARTIS : signs initial agreement to reserve capacity and implement the technol..
PU
13/04ERASMUS UNIVERSITY ROTTERDAM : A bifurcated approach to labour market integratio..
AQ
31/03NOVARTIS : expands targeted radioligand therapy pipeline with in-license for com..
AQ
31/03GENMAB A/S : Announces European Marketing Authorization for Kesimpta in Relapsin..
AQ
30/03NOVARTIS : receives EU approval for Kesimptaģ (ofatumumab), the first and only s..
PU
24/03Liquidia Corporation Reports Full-Year 2020 Financial Results and Provides Co..
AQ
24/03NOVARTIS : statement on comment in Swiss media
PU
23/03NOVARTIS INDIA : inaugurates innovative watershed project in India to increase w..
AQ
18/03NOVARTIS : awards $450,000 to eight nonprofit organizations through the STEP Pro..
AQ
10/03NOVARTIS : provides update on Phase III study evaluating canakinumab as second o..
AQ
08/03NOVARTIS : Challenging a young scientist to focus on patients
AQ
04/03NOVARTIS : signs initial agreement with CureVac to manufacture COVID-19 vaccine ..
PU
03/03NOVARTIS AG : - Novartis shareholders approve all resolutions proposed by the Bo..
AQ
01/03BEIGENE : Announces Closing of Collaboration with Novartis to Develop and Commer..
AQ
01/03NOVARTIS : Cosentyx gains EU label update for first-of-its-kind MAXIMISE data in..
AQ
01/03BEIGENE : Novartis strengthens Oncology pipeline with successful closing of tisl..
AQ
26/02NOVARTIS : strengthens Oncology pipeline with successful closing of tislelizumab..
PU
26/02NOVARTIS : Federal Court Holds Section 8.2 Of The PMNOC Regulations Does Not Imp..
AQ
26/02NOVARTIS : Cosentyxģ gains EU label update for first-of-its-kind MAXIMISE data i..
PU
19/02NOVARTIS : Gates Foundation to fund Novartis' development of a sickle cell disea..
AQ
18/02NOVARTIS : and the Bill and Melinda Gates Foundation collaborate to discover and..
AQ
17/02NOVARTIS : data show multiple sclerosis patients and nurses prefer Kesimpta Sens..
AQ
17/02NOVARTIS : Entresto granted expanded indication in chronic heart failure by FDA
AQ
16/02NOVARTIS : data show multiple sclerosis patients and nurses prefer Kesimptaģ (of..
PU
11/02NOVARTIS : Sandoz announces agreement to acquire GSK's cephalosporin antibiotics..
AQ
09/02NOVARTIS : receives FDA Breakthrough Therapy designations for investigational ST..
AQ
08/02NOVARTIS : receives FDA Breakthrough Therapy designations for investigational ST..
PU
02/02NOVARTIS : Federal Court Upholds Validity Of Two Patents Pertaining To ELIQUIS
AQ
01/02NOVARTIS : renews WHO medicine donation pledge with aim of ending leprosy
AQ
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op NOVARTIS AG
19/09/21
Komende gebeurtenissen in de sector